ANIP 52.11 ANI Pharmaceuticals Inc $ANIP Hit a 52 week high of 53.20 Closing the day 09:45 at 52.11 -0.59 -1.12% With a day low of 51.91 and a total volume of 25,067.
ANIP Recent Posts: http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/
ANIP ANI Pharmaceuticals Inc Recent Headline News
Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 44 mins ago
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 52.36 (-0.34), ICPT: 161.65 (-1.31), AMAG: 34.71 (-0.22), AFFX: 9.79 (+0.01)
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 51 mins ago
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 52.36 (-0.34)
ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 52.36 (-0.34), SCMP: 11.50 (+1.08)
Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 52.36 (-0.34)
Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 321.32 (+0.30), ANIP: 52.36 (-0.34), CLDX: 15.12 (+0.31), AMAG: 34.71 (-0.22)
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.01 (-0.08), ANIP: 52.36 (-0.34), ACGL: 57.61 (+0.19), ACCO: 8.92 (+0.06), FLWS: 9.18 (+0.15)
ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"
(NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health.
ANIP: 52.36 (-0.34)
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 24.15 (-0.17), HBNK: 20.20 (unch), ASMI: 41.41 (+0.41), RRGB: 69.78 (+0.02), SAPE: 24.73 (+0.10), PLUG: 4.27 (+0.03), ANIP: 52.36 (-0.34), ODP: 6.83 (-0.01), MTEX: 23.15 (+0.37), JAXB: 11.75 (-0.15), ALQA: 5.20 (+0.10), YRCW: 24.68 (-0.02)
Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST
FRM: 6.45 (-0.14), NEO: 4.90 (-0.04), AU: 8.82 (-0.18), FNHC: 26.15 (+0.37), AMS: 2.81 (+0.30), NYMX: 0.53 (-0.05), AMDA: 1.27 (+0.02), CVD: 100.74 (+0.01), GBIM: 6.48 (+0.03), RCAP: 9.79 (-1.80), KBIO: 2.09 (-0.02), COOL: 0.96 (+0.04), SAPE: 24.73 (+0.10), XTLB: 2.40 (-0.18), GERN: 2.39 (+0.02), ANIP: 52.36 (-0.34), BBLU: 1.38 (+0.07), NXTD: 2.47 (+0.01), AP: 18.95 (+0.26), ALQA: 5.20 (+0.10)
ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST
ANIP: 52.36 (-0.34)
ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 52.36 (-0.34)
ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST
ANIP: 52.36 (-0.34)
ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
PR Newswire - Mon Nov 03, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI" (NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and increased its revenue and non-GAAP EBITDA guidance for the fourth quarter of 2014.
ANIP: 52.36 (-0.34)
Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST
ACW: 4.94 (+0.07), SYY: 38.98 (+0.04), L: 43.11 (-0.14), EEP: 36.86 (+0.27), SNH: 22.33 (+0.01), INN: 11.57 (-0.04), ITG: 19.62 (+0.03), NSP: 33.60 (-0.22), S: 5.04 (+0.04), ALE: 50.84 (-0.41), GVA: 37.51 (-0.08), MCY: 55.28 (+0.14), ARNA: 4.83 (+0.13), CHD: 74.56 (+0.22), ARE: 83.09 (+0.34), USAK: 18.45 (-0.03), BWP: 16.96 (-0.10), KRG: 26.87 (+0.07), CYOU: 22.52 (-0.28), MNKD: 6.26 (+0.18), HNT: 49.92 (+0.47), AMH: 17.28 (+0.07), ARCB: 43.11 (-0.27), ANIP: 52.36 (-0.34), AMG: 198.98 (-1.25), HAE: 37.15 (+0.10), SOHU: 51.30 (+0.04), CNA: 39.23 (-0.30)
ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:51AM CDT
ANI Pharmaceuticals was a big mover last session, as its shares rose almost 7% on the day.
MDVN: 106.23 (-0.10), MACK: 8.45 (-0.10), ANIP: 52.36 (-0.34), ILMN: 190.94 (+4.02)
ANI Pharma reports November 3
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:35AM CDT
ANIP: 52.36 (-0.34)
5 Stocks Poised for Big Breakouts
at The Street - Mon Oct 27, 8:32AM CDT
These stocks look ready to break out and trade higher from current levels.
ANIP: 52.36 (-0.34), KTOS: 5.37 (+0.03), BLOX: 16.93 (+0.11), CSLT: 12.05 (-0.10), FPRX: 14.32 (-0.22)
ANI Pharmaceuticals Schedules Conference Call for Third Quarter 2014 Financial Results
PR Newswire - Mon Oct 27, 7:30AM CDT
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its third quarter and year-to-date 2014 financial results on Monday, November 3, 2014, before the opening of the U.S. financial markets. The earnings press release will be accessible through the Investor Relations section of the Company's website, www.anipharmaceuticals.com.
ANIP: 52.36 (-0.34)
3 Money-Making Biotech Stocks That Could Go Higher
Todd Campbell, The Motley Fool - Motley Fool - Fri Oct 24, 7:34AM CDT
Biotechnology investors often have to make bets based more on promise than profit. That's because it takes years and hundreds of millions of dollars to advance new medicine through clinical trials to market, so investing in biotech stocks is more of...
INSY: 38.90 (-0.75), ANIP: 52.36 (-0.34), AMGN: 161.47 (-0.46), NPSP: 29.50 (+0.33), TEVA: 58.21 (-0.23)
ANIP Recent Posts: http://investorshangout.com/ANI-Pharmaceutica...NIP-53540/
ANIP ANI Pharmaceuticals Inc Recent Headline News
Intercept Pharmaceuticals Slumps: ICPT Falls 5.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 44 mins ago
Intercept Pharmaceuticals has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past few days
ANIP: 52.36 (-0.34), ICPT: 161.65 (-1.31), AMAG: 34.71 (-0.22), AFFX: 9.79 (+0.01)
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 51 mins ago
Can the Rally in ANI Pharmaceuticals (ANIP) Shares Continue?
ANIP: 52.36 (-0.34)
ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 52.36 (-0.34), SCMP: 11.50 (+1.08)
Why ANI Pharmaceuticals (ANIP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 7:54AM CST
ANI Pharmaceuticals could be an interesting play for investors because of its positive short-term momentum and solid earnings estimate revisions
ANIP: 52.36 (-0.34)
Celldex Falls with Pipeline Update Overshadowing Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:57PM CST
Celldex Therapeutics, Inc. (CLDX) amended the protocol for a pivotal study being conducted on glembatumumab vedotin for the treatment of triple negative breast cancer.
BIIB: 321.32 (+0.30), ANIP: 52.36 (-0.34), CLDX: 15.12 (+0.31), AMAG: 34.71 (-0.22)
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ALLY: 23.01 (-0.08), ANIP: 52.36 (-0.34), ACGL: 57.61 (+0.19), ACCO: 8.92 (+0.06), FLWS: 9.18 (+0.15)
ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP
PR Newswire - Thu Nov 06, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"
(NASDAQ: ANIP) today announced the launch of Methazolamide USP 25mg and 50mg oral tablets, indicated for the treatment of ocular conditions. The US market for Methazolamide totals $24 million on a trailing 12 month basis, per IMS Health. ANIP: 52.36 (-0.34)
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:
SYKE: 24.15 (-0.17), HBNK: 20.20 (unch), ASMI: 41.41 (+0.41), RRGB: 69.78 (+0.02), SAPE: 24.73 (+0.10), PLUG: 4.27 (+0.03), ANIP: 52.36 (-0.34), ODP: 6.83 (-0.01), MTEX: 23.15 (+0.37), JAXB: 11.75 (-0.15), ALQA: 5.20 (+0.10), YRCW: 24.68 (-0.02)
Midday Gainers/ Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 11:49AM CST
FRM: 6.45 (-0.14), NEO: 4.90 (-0.04), AU: 8.82 (-0.18), FNHC: 26.15 (+0.37), AMS: 2.81 (+0.30), NYMX: 0.53 (-0.05), AMDA: 1.27 (+0.02), CVD: 100.74 (+0.01), GBIM: 6.48 (+0.03), RCAP: 9.79 (-1.80), KBIO: 2.09 (-0.02), COOL: 0.96 (+0.04), SAPE: 24.73 (+0.10), XTLB: 2.40 (-0.18), GERN: 2.39 (+0.02), ANIP: 52.36 (-0.34), BBLU: 1.38 (+0.07), NXTD: 2.47 (+0.01), AP: 18.95 (+0.26), ALQA: 5.20 (+0.10)
ANI Pharma ups revenues 123% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 8:21AM CST
ANIP: 52.36 (-0.34)
ANI posts 3Q profit
Automated Insights - Mon Nov 03, 7:46AM CST
BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Monday reported profit of $6.7 million in its third quarter.
ANIP: 52.36 (-0.34)
ANI Pharmaceuticals beats by $0.20, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 7:34AM CST
ANIP: 52.36 (-0.34)
ANI Pharmaceuticals Reports Record Third Quarter 2014 Financial Results and Year-To-Date Highlights
PR Newswire - Mon Nov 03, 7:30AM CST
ANI Pharmaceuticals, Inc. ("ANI"
(NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and increased its revenue and non-GAAP EBITDA guidance for the fourth quarter of 2014. ANIP: 52.36 (-0.34)
Notable earnings before Monday’s open
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:30PM CST
ACW: 4.94 (+0.07), SYY: 38.98 (+0.04), L: 43.11 (-0.14), EEP: 36.86 (+0.27), SNH: 22.33 (+0.01), INN: 11.57 (-0.04), ITG: 19.62 (+0.03), NSP: 33.60 (-0.22), S: 5.04 (+0.04), ALE: 50.84 (-0.41), GVA: 37.51 (-0.08), MCY: 55.28 (+0.14), ARNA: 4.83 (+0.13), CHD: 74.56 (+0.22), ARE: 83.09 (+0.34), USAK: 18.45 (-0.03), BWP: 16.96 (-0.10), KRG: 26.87 (+0.07), CYOU: 22.52 (-0.28), MNKD: 6.26 (+0.18), HNT: 49.92 (+0.47), AMH: 17.28 (+0.07), ARCB: 43.11 (-0.27), ANIP: 52.36 (-0.34), AMG: 198.98 (-1.25), HAE: 37.15 (+0.10), SOHU: 51.30 (+0.04), CNA: 39.23 (-0.30)
ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 7:51AM CDT
ANI Pharmaceuticals was a big mover last session, as its shares rose almost 7% on the day.
MDVN: 106.23 (-0.10), MACK: 8.45 (-0.10), ANIP: 52.36 (-0.34), ILMN: 190.94 (+4.02)
ANI Pharma reports November 3
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:35AM CDT
ANIP: 52.36 (-0.34)
5 Stocks Poised for Big Breakouts
at The Street - Mon Oct 27, 8:32AM CDT
These stocks look ready to break out and trade higher from current levels.
ANIP: 52.36 (-0.34), KTOS: 5.37 (+0.03), BLOX: 16.93 (+0.11), CSLT: 12.05 (-0.10), FPRX: 14.32 (-0.22)
ANI Pharmaceuticals Schedules Conference Call for Third Quarter 2014 Financial Results
PR Newswire - Mon Oct 27, 7:30AM CDT
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its third quarter and year-to-date 2014 financial results on Monday, November 3, 2014, before the opening of the U.S. financial markets. The earnings press release will be accessible through the Investor Relations section of the Company's website, www.anipharmaceuticals.com.
ANIP: 52.36 (-0.34)
3 Money-Making Biotech Stocks That Could Go Higher
Todd Campbell, The Motley Fool - Motley Fool - Fri Oct 24, 7:34AM CDT
Biotechnology investors often have to make bets based more on promise than profit. That's because it takes years and hundreds of millions of dollars to advance new medicine through clinical trials to market, so investing in biotech stocks is more of...
INSY: 38.90 (-0.75), ANIP: 52.36 (-0.34), AMGN: 161.47 (-0.46), NPSP: 29.50 (+0.33), TEVA: 58.21 (-0.23)
